Name: RIGEL PHARMACEUTICALS INC (RIGL) Stock
Brand: RIGEL PHARMACEUTICALS INC
Rating: 6.5 (3 reviews)

RIGL Latest News, Press Relases and Analysis

All

Press Releases

5 days ago - By: Chartmill - Mentions: EVC RUBI BW MTC ...

Keep an eye on the top gainers and losers in Wednesday's session.

6 days ago - By: Chartmill - Mentions: WWW EVC TREX RUBI ...

Wednesday's session: gap up and gap down stocks

4 days ago - By: Zacks Investment Research

Surging Earnings Estimates Signal Upside for Rigel (RIGL) Stock

4 days ago - By: Zacks Investment Research

All You Need to Know About Rigel (RIGL) Rating Upgrade to Strong Buy

5 days ago - By: Benzinga - Mentions: PRGO DAWN SUPN THAR ...

12 Health Care Stocks Moving In Wednesday's Intraday Session

5 days ago - By: Benzinga - Mentions: QS FUBO MRVL LMND ...

Johnson Controls, Babcock & Wilcox, Lemonade, Lumentum, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

6 days ago - By: Chartmill - Mentions: EVC TREX APPS AXON ...

These stocks that are showing activity before the opening bell on Wednesday.

6 days ago - By: Zacks Investment Research - Mentions: CATX

Rigel Pharmaceuticals (RIGL) Tops Q3 Earnings and Revenue Estimates

6 days ago - By: Chartmill - Mentions: TREX CDNA APPS AXON ...

What's going on in today's after hours session

6 days ago - By: Rigel Pharmaceuticals, Inc.

Rigel Reports Third Quarter 2025 Financial Results and Provides Business Update

8 days ago - By: Rigel Pharmaceuticals, Inc.

Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition

10 days ago - By: Zacks Investment Research - Mentions: VRTX ANIP EXAS

Rigel Gears Up to Report Q3 Earnings: Here's What to Expect

13 days ago - By: Rigel Pharmaceuticals, Inc.

Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update

13 days ago - By: Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Shows Strong Alignment with Navellier's Growth Criteria

15 days ago - By: Chartmill

Rigel Pharmaceuticals Inc (NASDAQ:RIGL) Presents a Compelling Case for Value Investors

21 days ago - By: Chartmill

RIGEL PHARMACEUTICALS INC (NASDAQ:RIGL) Combines Strong Growth and Bullish Technicals

a month ago - By: Rigel Pharmaceuticals, Inc.

Rigel Announces First Patient Enrolled in the Dose Expansion Phase of its Phase 1b Study of R289 in Patients with Lower-Risk MDS

a month ago - By: Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

2 months ago - By: Zacks Investment Research

What Makes Rigel Pharmaceuticals (RIGL) a Strong Momentum Stock: Buy Now?